Welcome to LookChem.com Sign In|Join Free
  • or
2,4-dimethoxy-3-methyl-1-(methoxymethoxy)benzene is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

126809-69-6

Post Buying Request

126809-69-6 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

126809-69-6 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 126809-69-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,6,8,0 and 9 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 126809-69:
(8*1)+(7*2)+(6*6)+(5*8)+(4*0)+(3*9)+(2*6)+(1*9)=146
146 % 10 = 6
So 126809-69-6 is a valid CAS Registry Number.

126809-69-6Downstream Products

126809-69-6Relevant academic research and scientific papers

Mitomycin synthetic studies: Stereocontrolled and convergent synthesis of a fully elaborated aziridinomitosane

Coleman, Robert S.,Felpin, Francois-Xavier,Chen, Wei

, p. 7309 - 7316 (2007/10/03)

Full details of a stereocontrolled and convergent synthetic route to 9a-desmethoxymitomycin A (1) are reported. The target molecule possesses the parent tetrahydropyrrolo[1,2-a]indole ring system characteristic of the mitomycin family of antitumor agents.

Synthesis of CC-1065/duocarmycin analogs

-

, (2008/06/13)

The present invention relates to a method for the synthesis of the dihydroindole C-ring found in CC-1065/duocarmycin analogs.

A Novel Class of CC-1065 and Duocarmycin Analogues Subject to Mitomycin-Related Reductive Activation

Boger, Dale L.,Garbaccio, Robert M.

, p. 8350 - 8362 (2007/10/03)

A new class of DNA alkylating agents is described that incorporate the quinone of the mitomycins, which is thought to impart tumor cell selectivity as a result of preferential reduction and activation in hypoxic tumors, into the AT-selective binding framework of the duocarmycins capable of mitomycin-like reductive activation and duocarmycin-like spirocyclization and subsequent DNA alkylation. Consistent with this design, the quinone prodrugs fail to alkylate DNA unless reductively activated and then do so with an adenine N3 alkylation sequence selectivity identical to that of the duocarmycins. Additionally, the agents exhibit a selectivity toward DT-Diaphorase (NQO1)-containing versus DT-Diaphorase-deficient (resistant) tumor cell lines, and they were shown to be effective substrates for reduction by recombinant human DT-Diaphorase. As such, the agents constitute effective duocarmycin and CC-1065 analogues subject to reductive activation. In addition, the solvolysis pH rate dependence of a series of reactive spirocyclopropanes revealed a unique and inverted order of reactivity at pH 7 versus pH 3. This behavior and the structural features responsible for it are consistent with an acid-catalyzed reaction at pH 3, but a direct uncatalyzed SN2 reaction at pH 7 that is not subject to acid catalysis.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 126809-69-6